FzioMed – Pioneering Biomaterials to Improve Patients’ Lives
FzioMed Company Description
FzioMed develops and commercializes absorbable surgical biomaterials based on its patented polymer science, for use in many surgical applications including spine, orthopedics, tendon, peripheral nerve, gynecology and general surgery.
• Oxiplex® spine gel helps reduce adhesion formation and related symptoms such as pain. CE marked and approved in over 70 countries.
• Dynavisc® adhesion barrier gel for tendon and peripheral nerve surgeries is CE marked and available in Europe, Australia and selected countries in the Middle East and Asia.
• Oxiplex/AP®, an effective adhesion barrier for peritoneal surgery and intrauterine applications helps reduce the incidence, extent, and severity of postoperative adhesions. CE marked and available in Europe, Australia and selected countries in the Middle East and Asia. Approval for Intrauterine application may be pending in some countries.
Brands: Oxiplex, Dynavisc, Oxiplex/AP